Melanoma is the most aggressive and deadly form of skin cancer. However, advances in the understanding of its biology have led to the development of several new therapeutic approaches. One of these novel treatment strategies is based on the targeting of the mitochondrial bioenergetic and networks responsible for tumor initiation and progression. Indeed, it has recently emerged that changes in mitochondrial metabolism, dynamics, redox homeostasis, and apoptosis are strictly associated with tumor growth, metastasis, and drug resistance. In this review, we summarize current evidence about the multiple biological functions exerted by mitochondria in melanoma, also focusing on the role of these organelles as promising targets for pharmacological intervention.

Mitochondrial bioenergetics and networks in melanoma: an update / G. Giannitti, A.J.J. Paganoni, S. Marchesi, R. Garavaglia, F. Fontana. - In: APOPTOSIS. - ISSN 1360-8185. - (2025 Jul 28). [Epub ahead of print] [10.1007/s10495-025-02155-4]

Mitochondrial bioenergetics and networks in melanoma: an update

G. Giannitti
Primo
;
A.J.J. Paganoni
Secondo
;
F. Fontana
Ultimo
2025

Abstract

Melanoma is the most aggressive and deadly form of skin cancer. However, advances in the understanding of its biology have led to the development of several new therapeutic approaches. One of these novel treatment strategies is based on the targeting of the mitochondrial bioenergetic and networks responsible for tumor initiation and progression. Indeed, it has recently emerged that changes in mitochondrial metabolism, dynamics, redox homeostasis, and apoptosis are strictly associated with tumor growth, metastasis, and drug resistance. In this review, we summarize current evidence about the multiple biological functions exerted by mitochondria in melanoma, also focusing on the role of these organelles as promising targets for pharmacological intervention.
Apoptosis; Cancer therapy; Melanoma; Mitochondrial dynamics; Mitochondrial metabolism; Redox homeostasis
Settore BIOS-10/A - Biologia cellulare e applicata
   Assegnazione Dipartimenti di Eccellenza 2023-2027 - Dipartimento di SCIENZE FARMACOLOGICHE E BIOMOLECOLARI
   DECC23_022
   MINISTERO DELL'UNIVERSITA' E DELLA RICERCA
28-lug-2025
28-lug-2025
Article (author)
File in questo prodotto:
File Dimensione Formato  
unpaywall-bitstream-365877390.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Licenza: Creative commons
Dimensione 1.74 MB
Formato Adobe PDF
1.74 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1182036
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
  • OpenAlex 1
social impact